Celyad Oncology SA (EBR:CYAD)
0.3110
-0.0080 (-2.51%)
Apr 30, 2026, 4:00 PM CET
Celyad Oncology Employees
As of December 31, 2025, Celyad Oncology had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees decreased by 14 or -73.68% compared to the previous year.
Employees
5
Change (1Y)
-14
Growth (1Y)
-73.68%
Revenue / Employee
€4,200
Profits / Employee
€166,000
Market Cap
13.92M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -14 | -73.68% | 4 | 1 |
| Dec 31, 2024 | 19 | 0 | - | 17 | 2 |
| Dec 31, 2023 | 19 | -19 | -50.00% | 17 | 2 |
| Dec 31, 2022 | 38 | -63 | -62.38% | 35 | 3 |
| Dec 31, 2021 | 101 | 10 | 10.99% | 95 | 6 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,765 |
| argenx SE | 1,863 |
| European Medical Solutions | 123 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 50 |
| Oxurion NV | 11 |
| BioSenic | 7 |
Celyad Oncology News
- 2 years ago - Celyad Oncology Earnings Call Transcript: H1 2023 - Transcripts
- 3 years ago - Celyad Oncology Earnings Call Transcript: H2 2022 - Transcripts
- 4 years ago - Celyad Oncology Earnings Call Transcript: H1 2022 - Transcripts